Elke De Wachter

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Harry Heijerman, Edward F. McKone, D.G. Downey et al. · The Lancet · 2019 · 1.4K citations · Full text

Life Sciences, Genetics, Pharmacology +14

Outcomes of a Delirium Prevention Program in Older Persons After Elective Surgery

Friederike Deeken, Alba Sánchez, Michael A. Rapp et al. · JAMA Surgery · 2021 · 147 citations · Full text

Medicine, Perioperative Medicine, Surgery +17

Microbiology of Bronchoalveolar Lavage Fluid in Children With Acute Nonresponding or Recurrent Community-Acquired Pneumonia: Identification of Nontypeable Haemophilus influenzae as a Major Pathogen

Iris De Schutter, Elke De Wachter, F. Crokaert et al. · Clinical Infectious Diseases · 2011 · 93 citations · Full text

Medicine, Microbiology, Pediatrics +17

The global impact of SARS-CoV-2 in 181 people with cystic fibrosis

Elliot McClenaghan, Rebecca Cosgriff, K. Brownlee et al. · Journal of Cystic Fibrosis · 2020 · 90 citations · Full text

Veterinary Medicine, Infectious Diseases, Pathobiology +6

Characteristics of Gastroesophageal Reflux and Potential Risk of Gastric Content Aspiration in Children With Cystic Fibrosis

Kathleen Blondeau, Ans Pauwels, Veerle Mertens et al. · Journal of Pediatric Gastroenterology and Nutrition · 2010 · 89 citations

Medicine, Child Health, Pediatrics +15